iMedX Inc., a leading healthcare software and services company, announced today that it has acquired the assets of PRN Medical Management, LLC (PRN), a medical transcription company serving medical clinics for over 18 years, primarily in Maryland, Washington DC, and Virginia. With the acquisition of PRN, iMedX expands its base in the Washington DC metro area and beyond. PRN’s employees in India will be absorbed by iMedX’s subsidiary Worldtech. Using iMedX’s revolutionary TurboScribe® platform for medical transcription, customers will enjoy the benefit of an efficient transcription workflow and ease of management. With TurboScribe’s integration with leading Electronic Medical Record (EMR) products, customers will progress towards a paperless environment, a higher quality of care, and pave the way for adherence to the Obama administration’s ‘meaningful use’ guidelines. Additionally, PRN’s customers can take advantage of iMedX’s other Internet-based products such as its TurboRecord® – iMedX’s low-cost, subscription-based EMR, and their ePrescribing product TurboRx® for error-free prescribing through pharmacies across the country.
Venkat Sharma, iMedX’s president and CEO, along with the current iMedX management team, will continue to lead the combined companies. PRN’s founder and CEO, Gabriela (“Gaby”) Perazzo will work with iMedX through the transition even as she develops her passion in online newsletters and seminars.
“With the evolution of Federal Government requirements for technology in healthcare, many small transcription companies are realizing they lack the resources to keep pace,” stated Venkat Sharma, iMedX’s president and CEO. “Forward-thinking companies, such as iMedX, with a scalable and seamless worldwide workforce and powerful technology to automate medical documentation management, are instrumental in achieving significant improvement in the quality of care. With the evolution of the Obama administration’s ‘meaningful use’ guidelines, it is imperative to use the online delivery and portability of medical documentation that iMedX provides.”
Mr. Sharma adds “Following on the heels of our acquisition of Medware, MedeFLow, and Worldtech last year, this acquisition is an essential part of our strategy to grow through direct sales as well as acquisitions, and propagate TurboScribe® software throughout our transcription customer base, concurrently rolling out other products to help the physician lower costs and increase revenues. Through this strategy iMedX intends to grow into a major force in the clinical documentation software and services industry.”